Location · St. Petersburg, FL
Clinical trials in St. Petersburg, FL
66 recruiting studies have a site in St. Petersburg, and 9 of them accept healthy volunteers.
66 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
Hoffmann-La Roche
- Location
- St. Petersburg, FL + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
Daiichi Sankyo
- Location
- St. Petersburg, FL + 2 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay…
American Laboratory Products Company
- Location
- St. Petersburg, FL + 5 other US sites
- Eligibility basics
- Ages 13+
- RecruitingHealthy volunteers
Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon
Lyv Life Inc. (dba: Cora)
- Location
- St. Petersburg, FL
- Eligibility basics
- Ages 18–49 · Women only
- RecruitingHealthy volunteers
Motiva Implants® Post-Approval Study
Motiva USA LLC
- Location
- St. Petersburg, FL + 32 other US sites
- Eligibility basics
- Ages 22+ · Women only
- RecruitingHealthy volunteers
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Acorn Biolabs Inc.
- Location
- St. Petersburg, FL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- St. Petersburg, FL + 70 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Novartis Pharmaceuticals
- Location
- St. Petersburg, FL + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Merck Sharp & Dohme LLC
- Location
- St. Petersburg, FL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Pfizer
- Location
- St. Petersburg, FL + 58 other US sites
- Eligibility basics
- Ages 35–80
- RecruitingPhase 3
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics
- Location
- St. Petersburg, FL + 18 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1/Phase 2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sanofi
- Location
- St. Petersburg, FL + 30 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A.
- Location
- St. Petersburg, FL + 5 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2/Phase 3
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Cabaletta Bio
- Location
- St. Petersburg, FL + 29 other US sites
- Eligibility basics
- Ages 6–75
- RecruitingPhase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Pfizer
- Location
- St. Petersburg, FL + 76 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Location
- St. Petersburg, FL + 51 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
DiscGenics, Inc.
- Location
- St. Petersburg, FL + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Pfizer
- Location
- St. Petersburg, FL + 7 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette);
Genentech, Inc.
- Location
- St. Petersburg, FL + 14 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Boehringer Ingelheim
- Location
- St. Petersburg, FL + 154 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Boehringer Ingelheim
- Location
- St. Petersburg, FL + 123 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Boehringer Ingelheim
- Location
- St. Petersburg, FL + 199 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Electra Therapeutics Inc.
- Location
- St. Petersburg, FL + 16 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- St. Petersburg, FL + 93 other US sites
- Eligibility basics
- Ages 18–130